DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+10.25%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$116M
AUM Growth
+$116M
(+20%)
Cap. Flow
+$9.18M
Cap. Flow
% of AUM
7.89%
Top 10 Holdings %
Top 10 Hldgs %
65.75%
Holding
56
New
9
Increased
9
Reduced
8
Closed
10
Top Buys
| 1 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
$7.62M |
| 2 |
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
|
$4.16M |
| 3 |
VXRT
Vaxart
VXRT
|
$2.46M |
| 4 |
Galmed Pharmaceuticals
GLMD
|
$2.32M |
| 5 |
AtriCure
ATRC
|
$2.15M |
Top Sells
| 1 |
GIVN
GIVEN IMAGING LTD
GIVN
|
$4.7M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$2.51M |
| 3 |
Stereotaxis
STXS
|
$1.52M |
| 4 |
Riot Platforms
RIOT
|
$1.36M |
| 5 |
Achieve Life Sciences
ACHV
|
$928K |
Sector Composition
| 1 | Healthcare | 69.95% |
| 2 | Financials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WINT
1
DELISTED
Windtree Therapeutics Inc
WINT
| $12.3M | 10.53% | 5,698,739 | – | – |
|
|
PCYC
2
DELISTED
PHARMACYCLICS INC
PCYC
| $11.1M | 9.53% | 110,628 +2,000 | +2% | +$200K |
|
|
3
AtriCure
ATRC
$1.84B
| $10.7M | 9.23% | 570,987 +114,286 | +25% | +$2.15M |
|
|
AMPE
4
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $10.3M | 8.87% | 1,625,703 +1,200,000 | +282% | +$7.62M |
|
|
NVDQ
5
DELISTED
Novadaq Technologies Inc.
NVDQ
| $5.87M | 5.05% | 263,541 -20,500 | -7% | -$457K |
|
|
6
Stereotaxis
STXS
$261M
| $5.87M | 5.05% | 1,381,460 -357,038 | -21% | -$1.52M |
|
7
Protalix BioTherapeutics
PLX
$124M
| $5.4M | 4.64% | 1,178,440 | – | – |
|
8
Insulet
PODD
$23.9B
| $5.19M | 4.46% | 109,418 -12,063 | -10% | -$572K |
|
|
NXTM
9
DELISTED
NxStage Medical Inc.
NXTM
| $4.89M | 4.21% | 384,154 | – | – |
|
|
DSCI
10
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $4.88M | 4.19% | 384,794 +327,785 | +575% | +$4.16M |
|
|
VXRT
11
DELISTED
Vaxart
VXRT
| $4.46M | 3.83% | 729,781 +402,591 | +123% | +$2.46M |
|
|
MACK
12
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $2.6M | 2.23% | 514,853 +172,400 | +50% | +$869K |
|
|
13
Galmed Pharmaceuticals
GLMD
$6.96M
| $2.32M | 1.99% | +202,100 | New | +$2.32M |
|
|
BEAT
14
DELISTED
BioTelemetry, Inc.
BEAT
| $2.18M | 1.87% | 215,645 | – | – |
|
|
BSTC
15
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.82M | 1.56% | 70,088 +18,396 | +36% | +$477K |
|
|
KERX
16
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.7M | 1.46% | 100,000 +56,000 | +127% | +$954K |
|
|
MTEM
17
DELISTED
Molecular Templates, Inc.
MTEM
| $1.29M | 1.11% | 270,500 -10,000 | -4% | -$47.6K |
|
|
SPNC
18
DELISTED
Spectranetics Corp
SPNC
| $1.28M | 1.1% | 42,162 -10,200 | -19% | -$309K |
|
|
XNPT
19
DELISTED
XENOPORT, INC.
XNPT
| $1.14M | 0.98% | 220,190 +42,828 | +24% | +$221K |
|
|
ELOS
20
DELISTED
Syneron Medical Ltd
ELOS
| $1.13M | 0.97% | 90,947 | – | – |
|
|
CRDC
21
DELISTED
CARDICA INC COM NEW (DE)
CRDC
| $1.06M | 0.91% | 1,053,704 -9,765 | -0.9% | -$9.78K |
|
|
UPI
22
DELISTED
UROPLASTY INC-NEW
UPI
| $1.05M | 0.9% | 289,332 | – | – |
|
|
CUTR
23
DELISTED
Cutera, Inc.
CUTR
| $992K | 0.85% | 88,694 | – | – |
|
24
Johnson & Johnson
JNJ
$427B
| $923K | 0.79% | 9,400 | – | – |
|
25
InspireMD
NSPR
$102M
| $875K | 0.75% | 286,724 | – | – |
|